Asr Vermogensbeheer N.V. United Therapeutics Corp Transaction History
Asr Vermogensbeheer N.V.
- $6.75 Trillion
- Q1 2025
A detailed history of Asr Vermogensbeheer N.V. transactions in United Therapeutics Corp stock. As of the latest transaction made, Asr Vermogensbeheer N.V. holds 1,227 shares of UTHR stock, worth $366,504. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,227Holding current value
$366,504% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
726Shares Held
41.4MCall Options Held
123KPut Options Held
100K-
Black Rock Inc. New York, NY5.47MShares$1.63 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.33 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$825 Million14.19% of portfolio
-
State Street Corp Boston, MA2.2MShares$657 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.09MShares$624 Million1.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $13.6B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...